title: Primary stabbing headache can be responsive to etoricoxib, a selective COX-2 inhibitor.
authors.forename: M B
authors.initials: MB
authors.lastname: O'Connor
authors.forename: E
authors.initials: E
authors.lastname: Murphy
authors.forename: M J
authors.initials: MJ
authors.lastname: Phelan
authors.forename: M J
authors.initials: MJ
authors.lastname: Regan
mesh_terms: D000208:Acute Disease / Q000628:therapy; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D000077613:Etoricoxib; D005260:Female; D051270:Headache Disorders, Primary / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use; D009882:Ophthalmic Nerve / Q000503:physiopathology; D010148:Intractable Pain / Q000188:drug therapy / Q000503:physiopathology; D011725:Pyridines / Q000008:administration & dosage*; D013450:Sulfones / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib; D007213:Indomethacin